Cancel
Brian Riley is a seasoned manufacturing executive with extensive experience in the biotechnology and pharmaceutical industries.
Brian Riley's Title
Brian Riley currently serves as the Chief Manufacturing Officer. In this executive role, he oversees all manufacturing operations, ensuring efficiency, compliance, and innovation within the company’s production processes. His leadership plays a crucial part in aligning manufacturing strategies with overall business objectives, driving both operational excellence and product quality.
Brian Riley's Education and Expertise
Brian Riley holds an MBA from Campbell University, which has equipped him with advanced business management skills essential for high-level strategic decision-making. Additionally, he earned a B.S. from North Carolina State University, providing him with a solid foundation in the scientific and technical aspects of manufacturing. His educational background is complemented by extensive expertise in quality assurance and operational efficiency.
Brian Riley's Background
Brian Riley boasts a robust background in the pharmaceutical and biotechnology industries, having held significant roles at leading companies. He spent five years at Catalent Pharma Solutions, where he advanced from General Manager, Biologics to Vice President of Operations. His career also includes pivotal roles at bioMerieux, Biogen Idec, Amgen, and Diosynth Biotechnology, where he focused on quality and operations. These experiences have honed his skills in managing complex manufacturing processes and leading large teams.
Brian Riley's Achievements
Throughout his career, Brian Riley has achieved notable success in various leadership positions. At Catalent Pharma Solutions, he significantly improved operational efficiencies and expanded biologics manufacturing capabilities. As the Site Director for Durham, NC operations at bioMerieux, he successfully managed site operations, contributing to the company’s growth and operational excellence. His tenure at Biogen Idec, Amgen, and Diosynth Biotechnology further underscores his ability to enhance quality control and streamline operations in highly regulated environments.
Report inaccurate information
